Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma have?
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma has 676 citations in the OpenAlex counts ScholarIQ stores.
When was Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma published?
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma has 2022 year in the ScholarIQ index.
What is the open-access status of Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma?
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma?
The DOI for Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma is on the source record.
What is the PMID of Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma?
The PMID for Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma is on the source record.
What is the OpenAlex record for Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma?
The OpenAlex for Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma is on the source record.